Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
PGLS - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CHTF18 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TTC39A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC100996792 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PSMB10 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CLDN15 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HOTAIRM1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
FLJ45513 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CTDSP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PMS2P5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RNF181 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TAF6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MEPCE - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MCM7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MAPRE2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HINT2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC4A2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMEM140 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MVB12A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on